Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stem Cell Transplantation | 9 | 2020 | 236 | 1.750 |
Why?
|
| Heart Defects, Congenital | 7 | 2024 | 1892 | 1.050 |
Why?
|
| Myocytes, Cardiac | 5 | 2020 | 665 | 0.980 |
Why?
|
| Pulmonary Valve | 2 | 2023 | 94 | 0.920 |
Why?
|
| Fontan Procedure | 3 | 2024 | 189 | 0.900 |
Why?
|
| Tetralogy of Fallot | 1 | 2023 | 176 | 0.690 |
Why?
|
| Heart Failure | 5 | 2020 | 2341 | 0.560 |
Why?
|
| Hypoplastic Left Heart Syndrome | 3 | 2018 | 276 | 0.550 |
Why?
|
| Heart Transplantation | 2 | 2024 | 873 | 0.540 |
Why?
|
| Ventricular Function, Right | 2 | 2015 | 126 | 0.520 |
Why?
|
| Myoblasts | 1 | 2017 | 31 | 0.510 |
Why?
|
| Ventricular Dysfunction | 1 | 2017 | 27 | 0.510 |
Why?
|
| Stroke Volume | 4 | 2020 | 531 | 0.450 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2023 | 436 | 0.430 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2024 | 1176 | 0.400 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2024 | 133 | 0.380 |
Why?
|
| Transposition of Great Vessels | 2 | 2024 | 126 | 0.380 |
Why?
|
| Heart Valve Diseases | 2 | 2023 | 173 | 0.370 |
Why?
|
| Postoperative Complications | 1 | 2024 | 3120 | 0.360 |
Why?
|
| Infant | 13 | 2024 | 13210 | 0.350 |
Why?
|
| Heart Valve Prosthesis | 2 | 2023 | 300 | 0.330 |
Why?
|
| Reoperation | 5 | 2024 | 835 | 0.310 |
Why?
|
| Aortic Valve Stenosis | 2 | 2023 | 338 | 0.310 |
Why?
|
| Treatment Outcome | 12 | 2024 | 12858 | 0.300 |
Why?
|
| Regeneration | 2 | 2020 | 230 | 0.270 |
Why?
|
| Transplantation, Autologous | 4 | 2024 | 272 | 0.240 |
Why?
|
| Heart Diseases | 2 | 2020 | 505 | 0.230 |
Why?
|
| Child, Preschool | 9 | 2024 | 14944 | 0.220 |
Why?
|
| Retrospective Studies | 9 | 2024 | 17483 | 0.210 |
Why?
|
| Stenosis, Pulmonary Artery | 1 | 2023 | 4 | 0.210 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2023 | 19 | 0.210 |
Why?
|
| Pulmonary Atresia | 1 | 2023 | 48 | 0.200 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2024 | 85 | 0.200 |
Why?
|
| Treatment Failure | 1 | 2024 | 350 | 0.200 |
Why?
|
| Cell- and Tissue-Based Therapy | 2 | 2020 | 154 | 0.190 |
Why?
|
| Heart Septal Defects | 1 | 2022 | 45 | 0.190 |
Why?
|
| Heterotaxy Syndrome | 1 | 2022 | 64 | 0.180 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2023 | 151 | 0.170 |
Why?
|
| Palliative Care | 4 | 2024 | 442 | 0.170 |
Why?
|
| Time Factors | 3 | 2024 | 6275 | 0.170 |
Why?
|
| Endocarditis | 1 | 2022 | 101 | 0.170 |
Why?
|
| Endocarditis, Bacterial | 1 | 2022 | 133 | 0.170 |
Why?
|
| Child | 9 | 2024 | 26096 | 0.170 |
Why?
|
| Humans | 20 | 2024 | 130912 | 0.160 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2022 | 181 | 0.160 |
Why?
|
| Immunity | 1 | 2020 | 178 | 0.160 |
Why?
|
| Recovery of Function | 3 | 2019 | 453 | 0.150 |
Why?
|
| Stem Cells | 2 | 2020 | 711 | 0.140 |
Why?
|
| Myoblasts, Cardiac | 1 | 2018 | 4 | 0.140 |
Why?
|
| Gene Editing | 1 | 2020 | 217 | 0.140 |
Why?
|
| Japan | 2 | 2015 | 173 | 0.130 |
Why?
|
| Follow-Up Studies | 2 | 2024 | 5256 | 0.130 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2017 | 19 | 0.130 |
Why?
|
| Infant, Newborn | 6 | 2024 | 8541 | 0.130 |
Why?
|
| Cardiac Catheterization | 2 | 2018 | 635 | 0.120 |
Why?
|
| Coronary Vessels | 2 | 2018 | 530 | 0.120 |
Why?
|
| Aortic Valve | 3 | 2023 | 449 | 0.120 |
Why?
|
| Heart | 1 | 2020 | 674 | 0.120 |
Why?
|
| Adolescent | 5 | 2024 | 20812 | 0.110 |
Why?
|
| Feasibility Studies | 2 | 2015 | 820 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2024 | 3675 | 0.110 |
Why?
|
| Echocardiography, Doppler | 1 | 2014 | 165 | 0.100 |
Why?
|
| Male | 7 | 2024 | 64819 | 0.100 |
Why?
|
| Heart Ventricles | 1 | 2018 | 772 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 993 | 0.100 |
Why?
|
| Female | 7 | 2024 | 70740 | 0.090 |
Why?
|
| Risk Factors | 2 | 2024 | 10900 | 0.090 |
Why?
|
| Young Adult | 1 | 2024 | 10037 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2015 | 6443 | 0.060 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 1134 | 0.060 |
Why?
|
| Autografts | 1 | 2024 | 29 | 0.050 |
Why?
|
| Dilatation, Pathologic | 1 | 2023 | 80 | 0.050 |
Why?
|
| Heart Valves | 1 | 2023 | 53 | 0.050 |
Why?
|
| Dilatation | 1 | 2023 | 70 | 0.050 |
Why?
|
| Norwood Procedures | 1 | 2024 | 103 | 0.050 |
Why?
|
| Infant, Low Birth Weight | 1 | 2023 | 170 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 227 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3833 | 0.050 |
Why?
|
| Age Factors | 2 | 2019 | 2866 | 0.040 |
Why?
|
| GATA4 Transcription Factor | 1 | 2020 | 38 | 0.040 |
Why?
|
| Mitral Valve | 1 | 2022 | 252 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2023 | 444 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 545 | 0.040 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 76 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2024 | 1069 | 0.040 |
Why?
|
| Survival Rate | 1 | 2024 | 2138 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2020 | 415 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2020 | 272 | 0.040 |
Why?
|
| Troponin T | 1 | 2020 | 252 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 1145 | 0.030 |
Why?
|
| Ventricular Function | 1 | 2018 | 87 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2018 | 459 | 0.030 |
Why?
|
| Myocardium | 1 | 2019 | 884 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3457 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2018 | 835 | 0.030 |
Why?
|
| Child Development | 1 | 2015 | 271 | 0.020 |
Why?
|
| Adult | 2 | 2023 | 31533 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2965 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 4492 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4680 | 0.020 |
Why?
|
| Animals | 2 | 2020 | 34275 | 0.020 |
Why?
|